CGNH CardioGenics (PNK) at $0.0001 on 75,300 volume 20 Mar 2026: short-term targets

CGNH stock jumped to USD 0.0001 on high intraday volume of 75,300 shares during market hours on 20 Mar 2026. This move follows thin float trading and a large prior price gap, pushing CardioGenics Holdings Inc (CGNH) into the top-gainers list on the PNK exchange in the United States. Traders reacted to liquidity shifts rather than fresh earnings, keeping fundamentals unchanged. We review price action, liquidity, key ratios, Meyka AI grading, and near-term price targets for CGNH stock.

CGNH stock price action and trading metrics

CGNH stock closed at USD 0.0001 on 20 Mar 2026. Volume spiked to 75,300, versus an average of 91 shares. Market cap sits at USD 12,000 with 120,000,000 shares outstanding. The intraday change printed +9,900.00% from the prior close of USD 0.000001, reflecting thin-market percentage distortion. These moves are typical for low-price PNK names and reflect short-term trading flows.

CGNH stock fundamentals and financials

CardioGenics Holdings Inc operates in Healthcare, Medical – Diagnostics & Research. Trailing metrics show net income per share of -0.02029 and cash per share of 0.00053. Price averages are 0.0001 (50-day) and 0.00008 (200-day). The company reports limited revenue per share and negative operating cash flow per share. These fundamentals indicate a high-risk speculative profile for CGNH stock.

CGNH stock technicals and momentum

Technical indicators are mixed for CGNH stock. RSI reads 51.85, signalling neutral momentum. CCI and MFI show overbought readings, with CCI at 466.67 and MFI at 100.00, consistent with a short-term spike. On-balance volume (OBV) is 163,518.00, showing recent buying pressure. Low ATR and flat moving averages reflect price compression before the breakout.

CGNH stock sector context and peer outlook

CGNH stock sits in the Healthcare sector. Diagnostics and point-of-care names show cautious investor demand this month. CardioGenics competes in immunoassay devices and cardiac markers. Sector trends favour companies with consistent revenue, which CGNH currently lacks. Sector performance therefore provides limited fundamental support for the current CGNH stock move.

Meyka AI rates CGNH with a score out of 100 and forecast

Meyka AI rates CGNH with a score out of 100: 64.90 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a near-term baseline target of USD 0.0002 and a bullish scenario of USD 0.0010. Compared with the current price of USD 0.0001, the baseline implies an upside of 100.00%, and the bullish scenario implies 900.00%. Forecasts are model-based projections and not guarantees.

CGNH stock risks, catalysts and trading strategy

Principal risks for CGNH stock include thin liquidity, limited revenues, and negative cash flows. Catalysts would be regulatory approvals, new commercial contracts, or transparent financial updates. Short-term traders should watch volume spikes and set strict risk limits. Long-term investors should demand consistent revenue and cash flow improvements before increasing exposure.

Final Thoughts

CGNH stock recorded a sharp intraday rise to USD 0.0001 on 20 Mar 2026, driven by heavy volume and thin-market dynamics. The move puts CardioGenics Holdings Inc in the top-gainers group on the PNK exchange during market hours, but fundamentals remain weak. Key ratios show negative net income per share (-0.02029) and very low cash per share (0.00053). Meyka AI’s baseline target is USD 0.0002, implying a 100.00% upside from the current price of USD 0.0001. A more aggressive scenario points to USD 0.0010, implying 900.00% upside, but that scenario requires meaningful operational improvements. Traders should treat CGNH stock as high volatility and speculative. We link the company site for filings and the quote snapshot for raw data: CardioGenics and FinancialModelingPrep CGNH. Meyka AI provides this market analysis as an AI-powered market analysis platform. Forecasts are model-based projections and not guarantees. Position sizing, stop-loss discipline, and verification of company disclosures are essential when trading CGNH stock.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.